Viewing data from:

BLISOVI 24 FE

ANDA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | A091398 | LUPIN LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Blisovi 24 Fe (2023)

Total Spending

$47K

Total Claims

800

Beneficiaries

271

Avg Cost/Unit

$0.88

Spending Trend

$130K(2019)→$103K(2020)→$87K(2021)→$54K(2022)→$47K(2023)

YoY Change:-4.5%

5yr CAGR:-10.3%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.02MG;1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 28, 2015

No patent or exclusivity listings for this strength.